New Findings Show COVID-19 Can Persist in Cancer Patients and Impact Treatments
Research reveals that COVID-19 can persist in the gastrointestinal tissues of cancer patients long after infection, potentially affecting treatment outcomes and inflammation levels. Learn more about these groundbreaking findings from the University of Minnesota.
Recent research conducted by the University of Minnesota Medical School has shed light on how COVID-19 can remain in the bodies of cancer patients long after initial infection, potentially influencing treatment outcomes. The study, published in iScience, focused on the persistent presence of the virus in gastrointestinal tissues of immunocompromised cancer patients, particularly those who had undergone transplant therapies. Researchers found that even six weeks after a positive nasal swab test, traces of the virus could still be detected in the gut lining. This lingering virus was associated with increased inflammation and tissue damage. Notably, a specific inflammatory marker, SERPINA1, was identified as being consistently linked to tissue inflammation in these cases.
The findings suggest that COVID-19’s persistence in the gastrointestinal tract might contribute to poorer outcomes during cancer treatment, especially in patients with elevated levels of inflammatory markers. Experts like Dr. Justin Hwang emphasized the potential importance of measuring GI tissue markers such as SERPINA1 before clinical decisions, particularly when considering transplantation therapies.
Furthermore, Dr. Emil Lou highlighted the significance of understanding if this persistent viral presence has longer-term effects, such as connections to Long COVID or other complications in this vulnerable population. The study underscores the need for further research involving larger cohorts to better understand the implications of persistent COVID-19 infection and the role of inflammation in cancer patients. Close monitoring may be necessary for patients with high SERPINA1 levels to mitigate increased inflammation risks associated with cancer treatments.
This study provides critical insights into the ongoing challenges posed by COVID-19 in immunocompromised patients, emphasizing the importance of tailored treatment strategies and further investigation into the virus’s long-term effects.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Reveals Over 40% of Deceased Drivers in Fatal Crashes Tested Positive for THC
A recent study shows that over 40% of drivers involved in fatal crashes tested positive for THC, highlighting ongoing public health concerns related to cannabis use and driving safety, even after legalization.
Nivolumab Preserves Quality of Life and Reduces Symptom Progression in Resectable NSCLC, Study Finds
A groundbreaking Phase III trial reveals that nivolumab maintains quality of life and reduces symptom worsening in patients with resectable non-small cell lung cancer, including those with advanced Stage III N2 disease.
Understanding How Caffeine Affects Children: Insights from a Pediatrician
Learn about the impact of caffeine on children's health, including risks, symptoms, and guidelines to keep kids safe from overstimulation and adverse effects.
UnitedHealth Under Federal Investigation for Alleged Medicare Fraud
UnitedHealth Group is under federal investigation for alleged Medicare fraud, raising concerns over billing practices in the US healthcare system amid leadership changes and stock declines.